Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season
- PMID: 31607599
- PMCID: PMC7126676
- DOI: 10.1016/j.vaccine.2019.10.005
Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season
Abstract
Purpose: Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined.
Results: We compared vaccination status of 2880 people with non-influenza respiratory viruses to 3240 people with pan-negative results. Comparing vaccinated to non-vaccinated patients, the adjusted odds ratio for non-flu viruses was 0.97 (95% confidence interval (CI): 0.86, 1.09; p = 0.60). Additionally, the vaccination status of 3349 cases of influenza were compared to three different control groups: all controls (N = 6120), non-influenza positive controls (N = 2880), and pan-negative controls (N = 3240). The adjusted ORs for the comparisons among the three control groups did not vary much (range: 0.46-0.51).
Conclusions: Receipt of influenza vaccination was not associated with virus interference among our population. Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections.
Keywords: Department of Defense; Influenza vaccine; Respiratory illness; Virus interference.
Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment in
-
Letter to the Editor.Vaccine. 2020 Jun 19;38(30):4651. doi: 10.1016/j.vaccine.2020.04.016. Epub 2020 May 26. Vaccine. 2020. PMID: 32471778 Free PMC article. No abstract available.
-
Seasonal Influenza Vaccination and the Heightened Risk of Coronavirus and Other Pandemic Virus Infections: Fact or Fiction?Indian Pediatr. 2020 Aug 15;57(8):767-768. doi: 10.1007/s13312-020-1936-1. Epub 2020 Jun 9. Indian Pediatr. 2020. PMID: 32525495 Free PMC article. No abstract available.
Similar articles
-
Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.Epidemiology. 2017 Jul;28(4):514-524. doi: 10.1097/EDE.0000000000000670. Epidemiology. 2017. PMID: 28362642 Free PMC article.
-
Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness.Clin Infect Dis. 2013 Sep;57(6):789-93. doi: 10.1093/cid/cit379. Clin Infect Dis. 2013. PMID: 23748138 Free PMC article.
-
Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol.BMC Infect Dis. 2018 Nov 6;18(1):550. doi: 10.1186/s12879-018-3444-7. BMC Infect Dis. 2018. PMID: 30400834 Free PMC article. Clinical Trial.
-
[Influenza and travelling].Med Mal Infect. 2006 Apr;36(4):190-5. doi: 10.1016/j.medmal.2005.12.005. Epub 2006 Apr 5. Med Mal Infect. 2006. PMID: 16600553 Free PMC article. Review. French.
-
Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients.J Infect Public Health. 2022 Apr;15(4):412-424. doi: 10.1016/j.jiph.2022.03.002. Epub 2022 Mar 9. J Infect Public Health. 2022. PMID: 35339014 Review.
Cited by
-
Identifying the Risk Factors of Adverse Pregnancy Outcomes among Women with COVID-19: A Population-Based Case-Control Study in Southern Iran.J Caring Sci. 2024 Apr 13;13(2):106-115. doi: 10.34172/jcs.33156. eCollection 2024 Jul. J Caring Sci. 2024. PMID: 39318730 Free PMC article.
-
Evaluation of the Effect of Influenza Vaccine on the Development of Symptoms in SARS-CoV-2 Infection and Outcome in Patients Hospitalized due to COVID-19.Vaccines (Basel). 2024 Jul 12;12(7):765. doi: 10.3390/vaccines12070765. Vaccines (Basel). 2024. PMID: 39066403 Free PMC article.
-
Decreased risk of non-influenza respiratory infection after influenza B virus infection in children.Epidemiol Infect. 2024 Apr 8;152:e60. doi: 10.1017/S0950268824000542. Epidemiol Infect. 2024. PMID: 38584132 Free PMC article. Clinical Trial.
-
[¿Disminuye la vacunación antigripal el riesgo de COVID-19? Estudio de casos y controles en un centro de Atención Primaria durante el año 2020.].Rev Esp Salud Publica. 2023 Oct 24;97:e202310087. Rev Esp Salud Publica. 2023. PMID: 37921395 Free PMC article. Spanish.
-
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome.NPJ Vaccines. 2023 Sep 29;8(1):145. doi: 10.1038/s41541-023-00739-2. NPJ Vaccines. 2023. PMID: 37773184 Free PMC article.
References
-
- National Vaccine Information Center. What is the History of Influenza Vaccine Use in America? <https://www.nvic.org/vaccines-and-diseases/influenza/vaccine-history.aspx> 2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
